Touch Respiratory

  • Home
  • Touch Respiratory

Touch Respiratory touchRESPIRATORY.com hosts the expert content from two peer-reviewed journals – EU Respiratory & P

This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations. The information posted on this channel is intended for use by licensed Healthcare Professionals (HCPs).

🚀 Stay ahead in the world of Respiratory & Pulmonary care!Get the latest research, insights, and expert opinions deliver...
11/07/2025

🚀 Stay ahead in the world of Respiratory & Pulmonary care!

Get the latest research, insights, and expert opinions delivered directly to your inbox.

Sign up for our touchRESPIRATORY newsletter and never miss a breakthrough in lung health.

🔬 From innovative treatments to clinical trial updates, we've got you covered.

💌 Join the community of healthcare professionals dedicated to making a difference.

👉 Click to subscribe now and stay informed: https://www.touchrespiratory.com/your-free-10-minutes.../...

🧫 Breaking the Biofilm Barrier in ICU Care – ATS 2025 HighlightsVentilator-associated pneumonia (VAP) remains a major IC...
10/07/2025

🧫 Breaking the Biofilm Barrier in ICU Care – ATS 2025 Highlights

Ventilator-associated pneumonia (VAP) remains a major ICU challenge. At , Prof. Frank MP van Haren shared a novel approach to tackling biofilm-associated infections in mechanically ventilated patients.

Explore how a new mucolytic strategy may enhance antibiotic effectiveness and reduce bacterial burden on endotracheal tubes – offering a potential breakthrough in VAP management.

📍Read more: https://touchrespiratory.com/insight/breaking-the-biofilm-barrier-a-new-approach-to-combatting-ventilator-associated-pneumonia-in-icu-patients-frank-mp-van-haren-ats-2025/

📢 New from ATS 2025 – Can Digital Tools Help Improve COPD Care?Medication adherence is a key challenge in the management...
09/07/2025

📢 New from ATS 2025 – Can Digital Tools Help Improve COPD Care?

Medication adherence is a key challenge in the management of COPD. This expert interview explores how a digital support package used in primary care may help reduce exacerbations and improve long-term outcomes for patients.

Discover the insights and practical takeaways from this real-world study.
👉 https://touchrespiratory.com/copd/conference-hub/improved-copd-outcomes-with-a-digital-adherence-support-package-findings-from-magnify/

🫁 Can childhood BMI shape your future lung health?A recent study featured by touchRESPIRATORY explores the long-term imp...
04/07/2025

🫁 Can childhood BMI shape your future lung health?

A recent study featured by touchRESPIRATORY explores the long-term impact of early-life BMI patterns on respiratory outcomes in young adulthood.

By tracking over 3,000 individuals from birth to age 24, researchers identified key BMI trajectories and examined their association with lung function and metabolomic markers—opening the door to new insights on prevention and early intervention.

Read more:
👉 https://touchrespiratory.com/insight/study-finds-early-bmi-patterns-shape-long-term-lung-health/

Curious about what your peers think on applying immunotherapy in clinical practice for patients with early-stage NSCLC? ...
04/07/2025

Curious about what your peers think on applying immunotherapy in clinical practice for patients with early-stage NSCLC?

Join our educational activity where real-time questions within the video ensure you won't miss a beat!

Discover what other HCPs think about immunotherapy in clinical practice for patients with early-stage NSCLC. Engage in live polling integrated seamlessly into this activity.

Be part of the experience, learn together: https://touchrespiratoryime.org/touchexpert-focus-immunotherapy-early-stage-nsclc/

🌍 Inhalers and the Environment: Can Respiratory Care Be More Sustainable?Treatments for asthma and COPD are lifesaving—b...
03/07/2025

🌍 Inhalers and the Environment: Can Respiratory Care Be More Sustainable?

Treatments for asthma and COPD are lifesaving—but they also carry a hidden environmental cost. Pressurised metered dose inhalers (pMDIs), commonly used in airway disease, contribute significantly to healthcare’s carbon footprint.

In this expert editorial, explore the environmental impact of inhaler use, the potential for lower-carbon alternatives, and the practical steps clinicians and healthcare systems can take to reduce emissions without compromising patient care.

💨 Read the full article: https://touchrespiratory.com/asthma/journal-articles/the-excessive-carbon-footprint-of-inhalers-used-in-airway-disease-and-its-remedies/

📢 ATS 2025 highlights now live!Catch up on the biggest updates in respiratory care from ATS 2025 🫁Our expert-led coverag...
02/07/2025

📢 ATS 2025 highlights now live!

Catch up on the biggest updates in respiratory care from ATS 2025 🫁

Our expert-led coverage breaks down the key takeaways, clinical insights and emerging trends shaping the future of respiratory medicine.

Topics include:
🔹 Developments in COPD and ILD
🔹 ICU care and mechanical ventilation strategies
🔹 Advances in pulmonary rehabilitation
🔹 Emerging biologics and real-world evidence

Explore the highlights now 👉 https://touchrespiratory.com/insight/ats-2025-highlights-expert-insights-and-key-takeaways-in-respiratory-care/

🌬️ Explore the full scope of respiratory medicine with touchRESPIRATORYFrom asthma and COPD to interstitial lung disease...
02/07/2025

🌬️ Explore the full scope of respiratory medicine with touchRESPIRATORY

From asthma and COPD to interstitial lung disease and pulmonary hypertension—our Specialties hub brings together the latest insights, expert interviews, and clinical updates across key areas of respiratory care.

Whether you're a specialist, researcher or HCP looking to stay informed, we've got you covered.

🧠 Start exploring: https://touchrespiratory.com/specialities/

📢 Dietetic Intervention in Interstitial Lung Disease (ILD)Could nutritional care be a missing link in ILD management?In ...
01/07/2025

📢 Dietetic Intervention in Interstitial Lung Disease (ILD)

Could nutritional care be a missing link in ILD management?

In this exclusive interview, Ras Kahai, Respiratory Dietitian at Royal Brompton Hospital, shares findings from the first-ever UK pilot trial exploring dietetic intervention in malnourished ILD patients.

🔍 Key highlights:
– Dietetic support helped stabilise weight loss
– Over 80% of patients receiving support felt better
– Strong patient engagement signals high unmet need
– Potential foundation for future clinical guidelines

Discover how personalised nutrition could shape the future of ILD care.

📖 Read: https://touchrespiratory.com/insight/dietetic-intervention-in-malnourished-patients-with-interstitial-lung-disease/

In case you missed it...💡 Refining immunotherapy in early-stage NSCLCAre you making the most of immunotherapy in your ea...
01/07/2025

In case you missed it...

💡 Refining immunotherapy in early-stage NSCLC

Are you making the most of immunotherapy in your early-stage NSCLC treatment plans?

In this expert-led session, thoracic surgeon Prof. Jonathan Spicer breaks down how to confidently integrate immunotherapy into neoadjuvant, perioperative and adjuvant care settings, backed by real-world clinical insights.

👨‍⚕️ Gain clarity on:
🔹 When and how to use immunotherapy
🔹 How to tailor treatment to individual patients
🔹 What to consider pre- and post-surgery

📺 Watch now and elevate your practice: https://touchrespiratoryime.org/touchexpert-focus-immunotherapy-early-stage-nsclc/

This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC.

The activity is jointly provided by USF Health and touchIME.

touchIME is an EBAC® accredited provider.

Address


Alerts

Be the first to know and let us send you an email when Touch Respiratory posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Touch Respiratory:

Shortcuts

  • Address
  • Alerts
  • Contact The Business
  • Claim ownership or report listing
  • Want your business to be the top-listed Media Company?

Share

Our Story

The information posted on this channel is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis or treatment recommendations.

European Respiratory & Pulmonary Diseases and US Respiratory & Pulmonary Diseases are peer-reviewed, free-to-access, annual journals specializing in the publication of balanced and comprehensive review articles written by leading authorities to address the most important and salient developments in the field of respiratory. The aim of these reviews is to break down the high science from 'data-rich' primary papers and provide practical advice and opinion on how this information can help physicians in the day to day clinical setting. Practice guidelines, symposium write-ups, case reports, and original research articles are also featured to promote discussion and learning amongst physicians, clinicians, researchers and related healthcare professionals. The journals are of interest to physicians, health care professionals and researchers across Europe and the US, providing practical advice relevant to the clinical setting on the diagnosis and treatment of respiratory conditions. European Respiratory & Pulmonary Diseases and US Respiratory & Pulmonary Diseases endeavour to support these professionals in continuously developing their knowledge, effectiveness and productivity. Articles are independently commissioned by the journals Managing Editor following specialist advice from the Editorial Board, which features the most senior experts within Respiratory. Industry-sponsored articles that are balanced and pertinent are also welcomed. The Editor is always keen to hear from leading authorities wishing to discuss potential submissions.